Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;16(3):30.
doi: 10.1007/s11892-016-0726-6.

Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus

Claudio Celentano  1 , Barbara Matarrelli  2 , Peter A Mattei  3 , Giulia Pavone  4 , Ester Vitacolonna  5 , Marco Liberati  6
Affiliations
Review

Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus

Claudio Celentano et al. Curr Diab Rep. 2016 Mar.

Abstract

Gestational diabetes mellitus (GDM) is a common complication characterized by increased insulin resistance, and by increased risk for adverse pregnancy outcomes affecting both the mother and the fetus. International guidelines describe optimal ways to recognize it, and the recommended treatment of patients affected to reduce adverse outcomes. Improving insulin resistance could reduce incidence of GDM and its complications. Recently, a few trials have been published on the possible prevention of GDM. Inositol has been proposed as a food supplement that might reduce gestational diabetes incidence in high-risk pregnant women.

Keywords: Adverse pregnancy outcome; Gestational diabetes mellitus; Insulin resistance; Myo-inositol; Prevention.

PubMed Disclaimer

References

    1. J Bone Miner Res. 2011 Mar;26(3):582-90 - PubMed
    1. Climacteric. 2012 Oct;15(5):490-5 - PubMed
    1. Obstet Gynecol. 2015 Aug;126(2):310-5 - PubMed
    1. J Nutr Sci Vitaminol (Tokyo). 2008 Jun;54(3):196-202 - PubMed
    1. Hum Psychopharmacol. 2011 Oct;26(7):526-30 - PubMed

LinkOut - more resources